122 related articles for article (PubMed ID: 1826714)
1. ImuVert therapy in the treatment of recurrent malignant astrocytomas: nursing implications.
Cress NB; Owens BM; Hill FH
J Neurosci Nurs; 1991 Feb; 23(1):29-33. PubMed ID: 1826714
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of Serratia marcescens extract in recurrent malignant astrocytoma.
Jaeckle KA; Mittelman A; Hill FH
J Clin Oncol; 1990 Aug; 8(8):1408-18. PubMed ID: 2199624
[TBL] [Abstract][Full Text] [Related]
3. Clinical trial of Serratia marcescens extract and radiation therapy in patients with malignant astrocytoma.
Black KL; Ciacci JD; Ammirati M; Selch MT; Becker DP
J Clin Oncol; 1993 Sep; 11(9):1746-50. PubMed ID: 8394880
[TBL] [Abstract][Full Text] [Related]
4. Hyperthermia treatment for malignant brain tumors: nursing management during therapy.
Edwards DK; Stupperich TK; Welsh DM
J Neurosci Nurs; 1991 Feb; 23(1):34-8. PubMed ID: 1849946
[TBL] [Abstract][Full Text] [Related]
5. Phase I trial of ImuVert (natural membrane vesicles associated with ribosomes) in patients with advanced cancer.
Mittelman A; Urban R; Wong G; Ahmed T; Arlin Z
Cancer Immunol Immunother; 1992; 35(5):331-4. PubMed ID: 1394337
[TBL] [Abstract][Full Text] [Related]
6. Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial.
Eck SL; Alavi JB; Alavi A; Davis A; Hackney D; Judy K; Mollman J; Phillips PC; Wheeldon EB; Wilson JM
Hum Gene Ther; 1996 Aug; 7(12):1465-82. PubMed ID: 8844206
[TBL] [Abstract][Full Text] [Related]
7. Recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2) immunotherapy with ranimustine chemotherapy and concurrent radiation therapy for malignant astrocytomas.
Fukushima T; Yamamoto M; Oshiro S; Tsugu H; Hirakawa K; Soma G
Anticancer Res; 2003; 23(6a):4473-81. PubMed ID: 14666736
[TBL] [Abstract][Full Text] [Related]
8. Intracranial astrocytoma: pathology, diagnosis and clinical presentation.
Willis D
J Neurosci Nurs; 1991 Feb; 23(1):7-14. PubMed ID: 1826721
[TBL] [Abstract][Full Text] [Related]
9. Treatment of recurrent high grade astrocytoma; results of a systematic review of 1,415 patients.
Huncharek M; Muscat J
Anticancer Res; 1998; 18(2B):1303-11. PubMed ID: 9615807
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of a new biological response modifier (ImuVert) in advanced prostate cancer.
Osborne CK; Craig JB; Klein K; Crawford ED; Turner J
Invest New Drugs; 1989 Jul; 7(2-3):243-5. PubMed ID: 2793381
[TBL] [Abstract][Full Text] [Related]
11. All-trans-retinoic acid: a phase II Radiation Therapy Oncology Group study (RTOG 91-13) in patients with recurrent malignant astrocytoma.
Phuphanich S; Scott C; Fischbach AJ; Langer C; Yung WK
J Neurooncol; 1997 Sep; 34(2):193-200. PubMed ID: 9210068
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of astrocytomas: an overview.
Armstrong TS; Gilbert MR
Semin Oncol Nurs; 1998 Feb; 14(1):18-25. PubMed ID: 9503511
[TBL] [Abstract][Full Text] [Related]
13. [Treatment modalities for malignant gliomas with reference to their pathophysiology].
Kobayashi S; Takakura K
Gan To Kagaku Ryoho; 1986 Jan; 13(1):11-7. PubMed ID: 3942392
[TBL] [Abstract][Full Text] [Related]
14. [Kinetics and composition of cell populations in malignant astrocytomas].
Arkhangel'skiĭ VV; Kotel'nikov VM; Kachkov IA
Zh Vopr Neirokhir Im N N Burdenko; 1980; (6):3-7. PubMed ID: 7468018
[TBL] [Abstract][Full Text] [Related]
15. The influence of ImuVert, a biological response modifier, on the growth and ganglioside composition of murine neural tumors.
Cotterchio M; Seyfried TN
Mol Chem Neuropathol; 1993 Oct; 20(2):163-72. PubMed ID: 8297420
[TBL] [Abstract][Full Text] [Related]
16. Salvage therapy with lomustine for temozolomide refractory recurrent anaplastic astrocytoma: a retrospective study.
Chamberlain MC
J Neurooncol; 2015 Apr; 122(2):329-38. PubMed ID: 25563816
[TBL] [Abstract][Full Text] [Related]
17. Gemistocytic astrocytomas: a reappraisal.
Krouwer HG; Davis RL; Silver P; Prados M
J Neurosurg; 1991 Mar; 74(3):399-406. PubMed ID: 1993905
[TBL] [Abstract][Full Text] [Related]
18. Thermoradiotherapy of recurrent malignant brain tumors.
Sneed PK; Gutin PH; Stauffer PR; Phillips TL; Prados MD; Weaver KA; Suen S; Lamb SA; Ham B; Ahn DK
Int J Radiat Oncol Biol Phys; 1992; 23(4):853-61. PubMed ID: 1319981
[TBL] [Abstract][Full Text] [Related]
19. Addition of IFN-alpha to treatment of malignant brain tumors.
Jereb B; Petric-Grabnar G; Klun B; Lamovec J; Skrbec M; Soos E
Acta Oncol; 1994; 33(6):651-4. PubMed ID: 7946443
[TBL] [Abstract][Full Text] [Related]
20. Locoregional treatment of malignant hepatic tumors with biologic response modifiers.
Yamamoto A; Sato T
Surg Oncol Clin N Am; 2008 Oct; 17(4):935-55, xii. PubMed ID: 18722927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
